Galectin Therapeutics Inc. has scheduled its 2025 annual meeting of stockholders for December 3, 2025. During the meeting, stockholders will vote on the election of eleven nominees for director to serve until the 2026 annual meeting. Additionally, they will vote on a non-binding advisory resolution to approve the compensation paid to Galectin's named executive officers. The meeting will also include a non-binding vote to recommend the frequency with which Galectin will conduct stockholder advisory votes on executive compensation. The meeting will be conducted in an online-only format.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Galectin Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001140361-25-038875), on October 22, 2025, and is solely responsible for the information contained therein.